Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Smith

Showing results (401-410 of 456) with videos related to

Pageof 46
Sort By:
Cancer Discovery|February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
Nature Communications|February 14, 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanomaElena Galvani, Piyushkumar A Mundra, Sara Valpione, et al.
Histopathology|August 4, 2017
HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissuesTalha Qaiser, Abhik Mukherjee, Chaitanya Reddy Pb, et al.
Proceedings. Biological Sciences|October 4, 2013
Predictive systems ecologyMatthew R Evans, Mike Bithell, Stephen J Cornell, et al.
The Lancet. Oncology|October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
Nature Chemical Biology|November 8, 2016
Inhibition of RAS function through targeting an allosteric regulatory siteRussell Spencer-Smith, Akiko Koide, Yong Zhou, et al.
The Lancet. Oncology|February 11, 2019
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Chris Parker, Fred Saad, et al.
Circulation Research|March 27, 2024
Cardiac GR Mediates the Diurnal Rhythm in Ventricular Arrhythmia SusceptibilityRoman Tikhomirov, Robert H Oakley, Cali Anderson, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne <i>bla</i><sub>KPC</sub> Carbapenemase in <i>Enterobacterales</i> in the United Kingdom from 2009 to 2014Nicole Stoesser, Hang T T Phan, Anna C Seale, et al.
Nature Human Behaviour|October 6, 2023
A new research agenda for African generative AIRachel Adams, Ayantola Alayande, Zameer Brey, et al.
Pageof 46

Showing results (401-410 of 456) with videos related to

Sort By:
Pageof 46
Cancer Discovery|February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
Nature Communications|February 14, 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanomaElena Galvani, Piyushkumar A Mundra, Sara Valpione, et al.
Histopathology|August 4, 2017
HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissuesTalha Qaiser, Abhik Mukherjee, Chaitanya Reddy Pb, et al.
Proceedings. Biological Sciences|October 4, 2013
Predictive systems ecologyMatthew R Evans, Mike Bithell, Stephen J Cornell, et al.
The Lancet. Oncology|October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
Nature Chemical Biology|November 8, 2016
Inhibition of RAS function through targeting an allosteric regulatory siteRussell Spencer-Smith, Akiko Koide, Yong Zhou, et al.
The Lancet. Oncology|February 11, 2019
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Chris Parker, Fred Saad, et al.
Circulation Research|March 27, 2024
Cardiac GR Mediates the Diurnal Rhythm in Ventricular Arrhythmia SusceptibilityRoman Tikhomirov, Robert H Oakley, Cali Anderson, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2020
Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne <i>bla</i><sub>KPC</sub> Carbapenemase in <i>Enterobacterales</i> in the United Kingdom from 2009 to 2014Nicole Stoesser, Hang T T Phan, Anna C Seale, et al.
Nature Human Behaviour|October 6, 2023
A new research agenda for African generative AIRachel Adams, Ayantola Alayande, Zameer Brey, et al.
Pageof 46